title: Medical treatment of male osteoporosis.
authors.affiliation: Departments of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Fonderico
authors.forename: M R
authors.initials: MR
authors.lastname: Fittipaldi
authors.forename: G
authors.initials: G
authors.lastname: Vitale
authors.forename: A
authors.initials: A
authors.lastname: Ciccarelli
authors.forename: G A
authors.initials: GA
authors.lastname: Lupoli
authors.forename: A
authors.initials: A
authors.lastname: Panico
authors.forename: T
authors.initials: T
authors.lastname: Cascella
authors.forename: G
authors.initials: G
authors.lastname: Lupoli
mesh_terms: D000284:Administration, Oral; D000368:Aged; D019386:Alendronate / Q000008:administration & dosage*; D015519:Bone Density / Q000187:drug effects; D002118:Calcium / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005272:Femur Neck / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology; D014807:Vitamin D / Q000627:therapeutic use*
chemical_list: D014807:Vitamin D; D002118:Calcium; D019386:Alendronate